FIELD: medicine.
SUBSTANCE: effective amount of a composition including isoquercetin, vitamin B3 and vitamin C is administered to a subject in need thereof.
EFFECT: invention provides treatment of venous thrombosis by inhibiting venous thrombus formation.
9 cl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR REDUCING SIGNIFICANT THROMBOTIC EVENTS IN PATIENTS WITH MALIGNANT TUMOR | 2019 |
|
RU2818766C2 |
| REDUCTION OF CHOLESTEROL LEVEL BY COMBINED APPLICATION OF QUERCETIN AND STATIN | 2009 |
|
RU2530769C2 |
| PROTEIN, PHARMACEUTICAL COMPOSITION, DRUG, DEVICE, KIT | 2019 |
|
RU2815577C2 |
| ANTIFIBRIN ANTIBODY FOR USE AS ANTITHROMBOTIC AGENT | 1995 |
|
RU2152801C2 |
| THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2019 |
|
RU2813780C2 |
| FACTOR Xa INHIBITOR SALT, METHOD FOR MAKING IT, BASED PHARMACEUTICAL COMPOSITION, TABLET, CAPSULE AND LOZENGE CONSISTING OF THIS COMPOSITION, METHOD FOR TREATING THROMBOSIS AND METHOD FOR INHIBITING BLOOD SAMPLE COAGULATION | 2006 |
|
RU2440986C2 |
| PLASMINOGEN FOR TREATMENT AND PREVENTION OF MICROTHROMBOSIS | 2020 |
|
RU2813699C2 |
| USE OF 2-PHENYL-3-ARAYLBENZOTHIOPHENES FOR THROMBOMODULINE EXPRESSION ENHANCEMENT | 1994 |
|
RU2125450C1 |
| ISOQUERCITRIN COMPOSITIONS | 2020 |
|
RU2768929C1 |
| THROMBOLYTIC AGENTS | 1995 |
|
RU2142799C1 |
